Nova Mentis Life Science (TSE:NOVA) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nova Mentis Life Science Corp. has announced an agreement to assign its intellectual property related to the mRNA Neuro Panel and Serotonin Assay to Ludwig Enterprises Inc. The deal includes debt forgiveness, stock issuance, and future royalties on commercialized revenue for NOVA. Amidst challenges in its Phase 2a clinical trial and the broader psychedelic sector, NOVA is seeking new business opportunities to enhance shareholder value.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.